Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-09 · accession 0001567619-22-015635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-11 | 2022-08-09 | BMRN | Davis George Eric | EVP, CLO | S - Sale+OE | $95.96 | -51.2K | 55.3K | -48% | -$4.91M |
| D | 2022-08-11 | 2022-08-09 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $67.81 | +47.5K | 102.8K | +86% | +$3.22M |
| D | 2022-08-11 | 2022-08-09 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $0.00 | -47.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | S | D | 47,526 | $95.93 | 55,251 | D | — | — | (F2) The price in column 4 is the weighted average price. The price actually received ranged from $95.540 to $96.400. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| 2 | Common | Common Stock | 2022-08-09 | M | A | 47,526 | $67.81 | 102,777 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-09 | S | D | 3,690 | $96.34 | 55,251 | D | — | — | (F1) The price in column 4 is the weighted average price. The price actually received ranged from $96.310 to $96.425. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| 4 | Derivative | Stock Option (Right to buy Common Stock) | 2022-08-09 | M | D | 47,526 | $0.00 | 0 | D | $67.81 · 2013-11-15 to 2023-05-14 | 47,526 Common Stock | (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |